NEW YORK (GenomeWeb News) – Millipore has acquired Oxford, UK-based BioAnaLab in a bid to expand its biopharmaceutical services offerings into the European market.
The Billerica, Mass.-based life science tools provider did not disclose the purchase price. It said that BioAnaLab's services include assay transfer and development, validation and sample analysis, pharmacokinetics and toxicokinetics, immunogenicity, biological potency, and vaccine services.
Millipore said that it would strengthen BioAnaLab's offerings with its own expertise in biomarker analytical services.
"BioAnaLab will add cGMP support testing capabilities to our portfolio, a solid customer base, and a team of highly talented services professionals with expertise in emerging scientific disciplines," Jonathan DiVincenzo, president of Millipore's Bioscience Division, said in a statement.